Therapeutic Progress of Mental Diseases ( Fourth):Alzheimer's Disease
10.3870/j.issn.1004-0781.2017.10.014
- VernacularTitle:精神疾病治疗进展(四):阿尔茨海默病
- Author:
Huilin WANG
1
;
Qingqing XU
;
Guoqing ZHENG
Author Information
1. 温州医科大学附属第二医院神经精神学科
- Keywords:
Donepezil;
Rivastigmine;
Galanthamine;
Memantine;
Alzheimer's disease
- From:
Herald of Medicine
2017;36(10):1148-1152
- CountryChina
- Language:Chinese
-
Abstract:
Alzheimer's disease ( AD) is the most common type of dementia. Currently, there is a lack of drugs that could effectively slow and halt the progression of AD. The present review describes the advancements in the treatment of AD, mainly including drugs for symptomatic control, drugs that control the behavioral and psychological symptoms of dementia, and some other drugs for AD and the non-pharmaceutical treatments. It is hoped that early diagnosis, early intervention and comprehensive therapy could relieve the symptoms and slow the progression of AD.
